Académique Documents
Professionnel Documents
Culture Documents
MALDI-TOF MS et détection
de la résistance aux
antibiotiques
DORTET Laurent
MALDI-TOF MS : C’est quoi ?
Comment çà marche ?
Temps de vol
Masse
OD = 0.07 Incubation
3h
200 μl Mueller-Hinton
+ Antibiotique
(1 dilution au dessus AUC avec
Relative Growth ≈
du cut off EUCAST) antibiotique
AUC sans antibiotique
Spectre
Cut-off
Avec Lysine
« heavy »
Etude de plusieurs
(10 à 20) pics
entre 2 et 10 kDa
Si ratio ≤ 1
Souche sensible
ratio
- A partir d’hémocultures
Incubation
with 3GC positives (Oviaño M et al.,
CMI 2014)
ESBL
Carbapenem
solution
Incubation 37°C
20 min – 4h Centrifugation
2 min 12000G
Surpernatant
Bacteria: loop 1-10 μL
Target :
Analysis of the spectra MALDI-TOF 11μL supernatant + 1μL matrix
STAR-BL
Principe :
Disparition du pic
correspondant à
l’imipénème natif (+/-
apparition du
métabolite résultant de
l’hydrolyse en présence
d’une carbapénèmase
Reproductibilité
variable du fait de
pratiques différentes :
- Carbapénème utilisé
- Equipement MALDI-TOF
- Read-out (+/- métabolite)
- Inoculum
- Temps d’incubation
E. coli NDM-1
E. cloacae GIM-1
E. cloacae OXA-48
E. coli OXA-48
E. coli OXA-181
Imipenem
K. pneumoniae VIM-1
K. pneumoniae KPC-3
K. pneumoniae OXA-48
Hydrolysis H
Final result
Colmar
*
5 60 5 10 Technical handling time
In-house
Incubation time
MALDI-TOF MS measurement
MBT STAR®-
Carba IVD Kit 10 30 5 10
*
Brest
In-house 5 20 5 10
Time (min)
* *
0 15 30 45 60 75 90
LPS modifications :
pEtN
O Antigen
Polymyxin L-Ara4N
+
Lipopolysacharride
+ Lipid deacylation
Repulsion Lipid acylation
+ +
Core
-OH
+ + +
- -- +
- +
Lipid A
Unmodified Modified
Lipid A ArnT operon
Lipid A
PmrE
L-Ara4N
addition O
H2N HO
HO
O
P
Hydroxylation O
Lipid A
HO HO
NH2
LpxO pEtN
PmrC
= =
addition
Mcr
Deacylation Acylation
LpxR PagP
Deacylation
PagL
Plasmatic
membrane
Lipid A
phosphorylation
Lipid A deacetylation
L-Ara4N addition
MCR-1
Plasmid encoded
phosphoethanolamine
transferase
Research workflow
Liters of Readout
bacterial Lipid
culture extraction Lipid A
MALDI-TOF
Day 0 Day 1 Day 2 Day 3 Day 4 1-3 weeks
Research workflow
Liters of Readout
bacterial Lipid
culture extraction Lipid A
MALDI-TOF
Routine workflow
Polymyxin
resistant
isolate
Bacterial
Identification _ +
MALDI-TOF Chromosome Plasmid
Day 0 Day 1 Day 2 Day 3 Day 4 1-3 weeks
Research workflow
Liters of Readout
bacterial Lipid
culture extraction Lipid A
MALDI-TOF
Routine workflow
2h Polymyxin 16-24 h
+
Plasmid
resistant
isolate _ Readout
Polymyxin NP test Colistin-MAC Chromosome MICs
(Dipicolinic acid
Patient 16-24 h 3-5 h inhibition)
samples
Bacterial
Identification _ +
MALDI-TOF Chromosome Plasmid
METHOD : Extraction and identification of lipid A
modifications directly on intact bacteria
15 min total
procedure
Patented MALDI-TOF
atypical matrix acquisition
Bacterial load Spectrum
analysis
4700 Reflector Spec #1=>BC=>AdvBC(32,0.5,0.2)=>NR(2.00)[BP = 1375.9, 948]
100
112.3
90
80
Intensity
70
60
I nt ensi t y
50
%
40
30
20
10
MALDI target
0
1600 1700 1800 1900 2000 2100
Mass (m/z)
m/z
O
P
pETN
O
HO
NH2
Lipide A natif
(1796 m/z)
Modified Lipid A
(1919 m/z)
Plasmid encoded pETN = Phosphoethanolamine
resistance group Dortet et al. Unpublished data
SUSCEPTIBLE RESISTANT
O
pETN
P
O
H2N HO
OH
Modified Lipid A
(1821 m/z)
O
P
pETN
O
HO
NH2
Lipide A natif
(1796 m/z)
Modified Lipid A
(1919 m/z)
Plasmid encoded pETN = Phosphoethanolamine
resistance group Dortet et al. Unpublished data
E. coli 100
4700 Refl ector Spec #1=>BC=>AdvBC(32, 0. 5, 0. 2)=>NR(2. 00)[BP = 1347. 7, 2935]
1796.2
1072. 0
Native Lipid A
(1796.2 m/z)
90
80
Intensity
70
Polymyxin
I nt ensi t y
60
50
susceptible
%
40
30
20
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
90
80
Polymyxin 70
Intensity
60
I nt ensi t y
resistant 50
%
mcr-1 positive 40
30
20
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1796.2 4700 Refl ector Spec #1=>BC=>AdvBC(32, 0. 5, 0. 2)=>NR(2. 00)[BP = 1376. 1, 931]
100 266. 3
90
Polymyxin 80
70
resistant
Intensity
60
I nt ensi t y
mcr-1 negative 50
%
40
30
20
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1796.2
1072. 0
Native Lipid A
(1796.2 m/z)
90
80
Intensity
70
Polymyxin
I nt ensi t y
60
50
susceptible
%
40
30
20
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1919.2
90
Modified Lipid A
80
Polymyxin 70
(1919.2 m/z)
Intensity
60
I nt ensi t y
resistant 50
%
mcr-1 positive 40
+ 123
30
(Plasmid) 20
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1796.2 4700 Refl ector Spec #1=>BC=>AdvBC(32, 0. 5, 0. 2)=>NR(2. 00)[BP = 1376. 1, 931]
100
90
266. 3
Native Lipid A
Polymyxin 80
(1796.2 m/z)
70
Resistant
Modified Lipid A
Intensity
60
I nt ensi t y
(Chromosome) 50
%
40
30
(1919.2 m/z)
1919.2
20 + 123
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1796.2
1072. 0
Native Lipid A
(1796.2 m/z)
90
80
Intensity
70
Polymyxin
I nt ensi t y
60
50
susceptible
%
40
30
20
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1919.2
90
+ 25 Modified Lipid A
80
Polymyxin 70
(1919.2 m/z)
Intensity
60
I nt ensi t y
resistant 50
%
mcr-1 positive 40
+ 123
30
Modified Lipid A
20
10 (1821.2 m/z)
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1796.2 4700 Refl ector Spec #1=>BC=>AdvBC(32, 0. 5, 0. 2)=>NR(2. 00)[BP = 1376. 1, 931]
100
90
266. 3
Native Lipid A
Polymyxin 80
(1796.2 m/z)
70
resistant
Modified Lipid A
Intensity
60
I nt ensi t y
mcr-1 negative 50
%
40
30
(1919.2 m/z)
1919.2
20 + 123
10
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
4
4.5
100
1072. 0
3.5
4.0
80
70
Polymyxin 3
3.5
I nt ensi t y
60
50
%
susceptible 40
30
20
10
2.5
3.0
0
1600 1720 1840 1960 2080 2200
M ass ( m / z)
1
4700 Refl ector Spec #1=>BC=>AdvBC(32, 0. 5, 0. 2)=>NR(2. 00)[BP = 1376. 1, 665]
80
1.9
70
1.8
Polymyxin
Intensity
60
I nt ensi t y
1.7
resistant
le
e)
e)
50
%
t ib
t iv
tiv
40
1.6
mcr-1 positive
ep
ga
si
30
po
1.5
sc
ne
20
1.5
su
cr
cr
10
m
m
1.4
t(
i
0
t(
1600 1720 1840 1960 2080 2200
yx
M ass ( m / z)
an
an
1840m/z 1.3
m
1600 1720 1960 2080 2200
st
st
ly
si
Po
si
1.2
re
re
in
n
4700 Refl ector Spec #1=>BC=>AdvBC(32, 0. 5, 0. 2)=>NR(2. 00)[BP = 1376. 1, 931]
1.1
yx
yx
100 266. 3
ym
m
1
90
1.0
ly
l
Po
80
Polymyxin
Po
70
0.9
Intensity
resistant 60
I nt ensi t y
50
0.8
%
mcr-1 negative 40
30 0.7
0.6
20
10
0
1600 1720 1840
M ass ( m / z)
1960 2080 2200
0.5
0.5
1600 1720 1840m/z 1960 2080 2200 0.4
0.3
0.2
0.1
0.0
le
e)
e)
Polymyxin Chromosome Plasmid-encoded
ib
tiv
tiv
pt
si
ga
e
po
encoded (mcr-like)
sc
ne
susceptible
su
cr
cr
(m
m
ni
t(
yx
nt
n
Polymyxin resistant
ym
ta
ta
s
is
l
si
Po
re
re
n
n
xi
xi
Already validated on :
Research workflow
Liters of Readout
bacterial Lipid
culture extraction Lipid A
MALDI-TOF
Routine workflow
2h Polymyxin 16-24 h
+
Plasmid
resistant
isolate _ Readout
Polymyxin NP test Colistin-MAC Chromosome MICs
(Dipicolinic acid
Patient 16-24 h 3-5 h inhibition)
samples
Bacterial
Identification _ +
MALDI-TOF Chromosome Plasmid
Research workflow
Liters of Readout
bacterial Lipid
culture extraction Lipid A
MALDI-TOF
Routine workflow
2h Polymyxin 16-24 h
+
Plasmid
resistant
isolate _ Readout
Polymyxin NP test Colistin-MAC Chromosome MICs
(Dipicolinic acid
Patient 16-24 h 3-5 h inhibition)
samples
Bacterial
Identification _ +
MALDI-TOF Chromosome Plasmid
15 min
MALDI assay
Polymyxin susceptibility (R / S) Readout
AND
Plasmid vs chromosome Lipid A
encoded resistance Dortet et al. Unpublished data
Détection de protéines directement responsables
de la résistance (β-lactamases, PLP2a)
Difficultés de standardisation
MBT STAR BL
Functional assay monitoring β-
lactamase activity
MBT ASTRA
Semi-quantitative growth assay using an
internal standard
All antibiotics
Merci de votre attention